Markets Gone Wild

Hepion Pharmaceuticals Receives European Patent for Rencofilstat Patent Covers 38 European Countries Rencofilstat’s Exclusivity May Extend into 2048 EDISON, N.J., March 02, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), fibrotic diseases, hepatocellular carcinoma (“HCC”),…

PC Magazine Selects Data443’s Ransomware Recovery Manager as One of the Best Ransomware Protections In a recent announcement, Data443 Risk Mitigation, Inc. revealed that PC Magazine has recognized their Ransomware Recovery Manager (RRM) as one of the top ransomware protection solutions in the market. The software was awarded the titles of “Best of Inexpensive Protection”…

Checkpoint Therapeutics Announces FDA Filing Acceptance of Biologics License Application for Cosibelimab in Metastatic Understanding the Prescription Drug User Fee Act (“PDUFA”) Goal Date On January 3, 2024, the Prescription Drug User Fee Act (“PDUFA”) goal date for Cosibelimab in Metastatic will mark a significant milestone for Checkpoint Therapeutics, Inc. The FDA has indicated that…

Increasing Interest towards Vehicle Automation to Drive the Driver Assistance System Market New York, US, March 02, 2023 (GLOBE NEWSWIRE) — Market Research Future (MRFR) Report Overview: According to a detailed research report by Market Research Future (MRFR), the Driver Assistance System Market is expected to witness significant growth in the coming years. The report…

Deutsche Börse’s cash markets turnover drops 35% YoY but strengthens slightly on monthly basis in February Trading volumes on Börse Frankfurt In February 2023 came in at €2.93 billion, down from €3.01 billion in January 2023. Equities on Deutsche Börse generated € 96.93 billion last month, while trading in ETFs/ETCs/ETNs accounted for €14.84 billion of…

Option Care Health Announces Pricing of Secondary Offering of 13,000,000 Shares of Common Stock and Common Stock Repurchase BANNOCKBURN, Ill., March 01, 2023 (GLOBE NEWSWIRE) — Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the “Selling Stockholder”) has agreed to sell…

Oh No, Another Shareholder Alert! Here we go again, folks. It seems like every other day there is news about yet another company being investigated for claims of wrongdoing. This time, it’s CVRx, Inc. (NASDAQ: CVRX) in the hot seat. According to a recent press release from Pomerantz LLP, they are looking into allegations involving…

BLRX DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important March 6 Deadline in Securities Class Action – BLRX Background Information NEW YORK, March 02, 2023 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BioLineRx Ltd. (NASDAQ:…